Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. (2018)
Attributed to:
Antioxidant defence in adrenocortical cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/eje-18-0042
PubMed Identifier: 29500309
Publication URI: http://europepmc.org/abstract/MED/29500309
Type: Journal Article/Review
Volume: 178
Parent Publication: European journal of endocrinology
Issue: 5
ISSN: 0804-4643